Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis
Novartis
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Noema Pharma AG
Astellas Pharma Inc
Quadriga Biosciences, Inc.
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Takeda
MetVital, Inc.
Novartis